Rautio, Jarkko.
Jarkko Rautio
VIAF ID: 159936140 (Personal)
Permalink: http://viaf.org/viaf/159936140
Preferred Forms
- 100 0 _ ‡a Jarkko Rautio
- 100 1 _ ‡a Rautio, Jarkko
-
- 100 1 _ ‡a Rautio, Jarkko
-
- 100 1 _ ‡a Rautio, Jarkko
-
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Amino acid ester prodrugs conjugated to the α-carboxylic acid group do not display affinity for the L-type amino acid transporter 1 (LAT1). | |
Amino acid prodrugs for oral delivery: challenges and opportunities | |
Amino Acid Promoieties Alter Valproic Acid Pharmacokinetics and Enable Extended Brain Exposure | |
Aminocarbonyloxymethyl ester prodrugs of flufenamic acid and diclofenac: suppressing the rearrangement pathway in aqueous media | |
Brain pharmacokinetics of ganciclovir in rats with orthotopic BT4C glioma | |
Convenient microwave-assisted synthesis of lipophilic sulfenamide prodrugs of metformin | |
Design, synthesis and brain uptake of LAT1-targeted amino acid prodrugs of dopamine. | |
Evaluation of hydroxyimine as cytochrome P450-selective prodrug structure | |
Evaluation of novel imidazotetrazine analogues designed to overcome temozolomide resistance and glioblastoma regrowth. | |
The first bioreversible prodrug of metformin with improved lipophilicity and enhanced intestinal absorption. | |
Free fatty acid receptor 1 (GPR40) agonists containing spirocyclic periphery inspired by LY2881835. | |
Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats. | |
Glutathione-S-transferase selective release of metformin from its sulfonamide prodrug | |
How readily does ketorolac penetrate cerebrospinal fluid in children? | |
In vitro and in vivo evaluation of a sulfenamide prodrug of basic metformin | |
In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates. | |
Inefficient central nervous system delivery limits the use of ibuprofen in neurodegenerative diseases. | |
Inhibitors of LRRK2 kinase activity to probe the treatment option in Parkinson's disease | |
Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders | |
Large neutral amino acid transporter enables brain drug delivery via prodrugs | |
LAT1-mediated prodrug uptake: a way to breach the blood-brain barrier? | |
Midazolam exhibits characteristics of a highly permeable P-glycoprotein substrate. | |
Novel cyclic phosphate prodrug approach for cytochrome P450-activated drugs containing an alcohol functionality | |
Piperazinylalkyl prodrugs of naproxen improve in vitro skin permeation | |
Plasma and cerebrospinal fluid concentrations of indomethacin in children after intravenous administration. | |
Prodrug approaches for CNS delivery | |
[Prodrug technology in the development of medicinal agents] | |
Prodrugs - an efficient way to breach delivery and targeting barriers. | |
Prodrugs and targeted delivery : towards better ADME properties | |
Prodrugs: design and clinical applications. | |
Prodrugs--from serendipity to rational design. | |
Prodrugs in medicinal chemistry and enzyme prodrug therapies | |
Prodrugs - Recent approvals and a glimpse of the pipeline. | |
Quantitative insight into the design of compounds recognized by the L-type amino acid transporter 1 (LAT1). | |
Role of L-Type Amino Acid Transporter 1 (LAT1) for the Selective Cytotoxicity of Sesamol in Human Melanoma Cells | |
Structure-activity relationship study of compounds binding to large amino acid transporter 1 (LAT1) based on pharmacophore modeling and in situ rat brain perfusion | |
Synthesis and antileishmanial activity of novel buparvaquone oxime derivatives. | |
Synthesis and in vitro evaluation of novel naproxen and ketoprofen prodrugs for topical drug delivery, 2000: | |
Synthesis, in vitro and in vivo characterization of novel ethyl dioxy phosphate prodrug of propofol. | |
Synthesis, stability and in vitro dermal evaluation of aminocarbonyloxymethyl esters as prodrugs of carboxylic acid agents. | |
Tyrosine-Chlorambucil Conjugates Facilitate Cellular Uptake through L-Type Amino Acid Transporter 1 (LAT1) in Human Breast Cancer Cell Line MCF-7 |